Accelerating COVID-19 Vaccination Among People Living With HIV and Health Care Workers in Tanzania: A Case Study.


Journal

Global health, science and practice
ISSN: 2169-575X
Titre abrégé: Glob Health Sci Pract
Pays: United States
ID NLM: 101624414

Informations de publication

Date de publication:
28 May 2024
Historique:
received: 30 10 2023
accepted: 30 04 2024
medline: 29 5 2024
pubmed: 29 5 2024
entrez: 28 5 2024
Statut: aheadofprint

Résumé

There is limited evidence on COVID-19 vaccination uptake among people living with HIV (PLHIV) and health care workers (HCWs), with the current evidence concentrated in high-income countries. There is also limited documentation in the published literature regarding the feasibility and lessons from implementing targeted vaccination strategies to reach PLHIV and HCWs in low- and middle-income countries. We designed and implemented multifaceted strategies to scale up targeted COVID-19 vaccination among PLHIV and HCWs in 11 administrative regions on the mainland of Tanzania plus Zanzibar. An initial 6-week intensification strategy was implemented using a diverse partnership model comprising key stakeholders at the national- and subnational levels. A layered package of strategies included expanding the number of certified vaccinators, creating vaccination points within HIV clinics, engaging HCWs to address their concerns, and building the capacity of HCWs as "champions" to promote and facilitate vaccination. We then closely monitored COVID-19 vaccination uptake in 562 high-volume HIV clinics. Between September 2021 and September 2022, the proportion of fully vaccinated adult PLHIV increased from <1% to 97% and fully vaccinated HCWs increased from 23% to 80%. Our intra-action review highlighted the importance of leveraging a strong foundation of existing partnerships and platforms, integrating COVID-19 vaccination points within HIV clinics, and refining strategies to increase vaccination demand while ensuring continuity of vaccine supply to meet the increased demand. Lessons from Tanzania can inform targeted vaccination of vulnerable groups in future health emergencies.

Sections du résumé

BACKGROUND BACKGROUND
There is limited evidence on COVID-19 vaccination uptake among people living with HIV (PLHIV) and health care workers (HCWs), with the current evidence concentrated in high-income countries. There is also limited documentation in the published literature regarding the feasibility and lessons from implementing targeted vaccination strategies to reach PLHIV and HCWs in low- and middle-income countries.
PROGRAM DEVELOPMENT, PILOTING, AND IMPLEMENTATION UNASSIGNED
We designed and implemented multifaceted strategies to scale up targeted COVID-19 vaccination among PLHIV and HCWs in 11 administrative regions on the mainland of Tanzania plus Zanzibar. An initial 6-week intensification strategy was implemented using a diverse partnership model comprising key stakeholders at the national- and subnational levels. A layered package of strategies included expanding the number of certified vaccinators, creating vaccination points within HIV clinics, engaging HCWs to address their concerns, and building the capacity of HCWs as "champions" to promote and facilitate vaccination. We then closely monitored COVID-19 vaccination uptake in 562 high-volume HIV clinics. Between September 2021 and September 2022, the proportion of fully vaccinated adult PLHIV increased from <1% to 97% and fully vaccinated HCWs increased from 23% to 80%.
LESSONS AND IMPLICATIONS UNASSIGNED
Our intra-action review highlighted the importance of leveraging a strong foundation of existing partnerships and platforms, integrating COVID-19 vaccination points within HIV clinics, and refining strategies to increase vaccination demand while ensuring continuity of vaccine supply to meet the increased demand. Lessons from Tanzania can inform targeted vaccination of vulnerable groups in future health emergencies.

Identifiants

pubmed: 38806223
pii: GHSP-D-23-00281
doi: 10.9745/GHSP-D-23-00281
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Jalloh et al.

Auteurs

Mohamed F Jalloh (MF)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania. yum8@cdc.gov.

Florian Tinuga (F)

Immunization and Vaccine Development, Tanzania Ministry of Health, Dar es Salaam, Tanzania.

Mohamed Dahoma (M)

Zanzibar Integrated HIV, Hepatitis, TB and Leprosy Program, Zanzibar, Tanzania.

Anath Rwebembera (A)

National AIDS Control Programme, Tanzania Ministry of Health, Dodoma, Tanzania.

Ntuli A Kapologwe (NA)

President's Office - Regional Administration and Local Government, Dodoma, Tanzania.

Daniel Magesa (D)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Kokuhabwa Mukurasi (K)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Oscar Ernest Rwabiyago (OE)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Jaiving Kazitanga (J)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Angela Miller (A)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

David Sando (D)

Management and Development for Health, Dar es Salaam, Tanzania.

Haruka Maruyama (H)

Tanzania Country Office, ICAP at Columbia University, Dar es Salaam, Tanzania.

Redempta Mbatia (R)

Tanzania Health Promotion Support, Dar es Salaam, Tanzania.

Florence Temu (F)

Tanzania Country Office, Amref Health Africa, Dar es Salaam, Tanzania.

Eva Matiko (E)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Kokuhumbya Kazaura (K)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Prosper Njau (P)

National AIDS Control Programme, Tanzania Ministry of Health, Dodoma, Tanzania.

Jennifer Imaa (J)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Tara Pinto (T)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Sophia A Nur (SA)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Nicolas Schaad (N)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Augustine Malero (A)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Damian Damian (D)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Jonathan Grund (J)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

George S Mgomella (GS)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Alison Johnson (A)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Gbolahan Cole (G)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Eunice Mmari (E)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Wangeci Gatei (W)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Mahesh Swaminathan (M)

Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.

Classifications MeSH